CR20110126A - Sales de n-[6-(cis-2,6-dimetil-morfolin-4-il) -piridin-3-il] -2-metil-4'-(trifluoro-metoxi)-[1,1'-bifenil]-3-carboxamida - Google Patents

Sales de n-[6-(cis-2,6-dimetil-morfolin-4-il) -piridin-3-il] -2-metil-4'-(trifluoro-metoxi)-[1,1'-bifenil]-3-carboxamida

Info

Publication number
CR20110126A
CR20110126A CR20110126A CR20110126A CR20110126A CR 20110126 A CR20110126 A CR 20110126A CR 20110126 A CR20110126 A CR 20110126A CR 20110126 A CR20110126 A CR 20110126A CR 20110126 A CR20110126 A CR 20110126A
Authority
CR
Costa Rica
Prior art keywords
trifluoro
cis
salts
methyl
bifenil
Prior art date
Application number
CR20110126A
Other languages
English (en)
Inventor
Joginder Singh Bajwa
La Cruz Marilyn De
Stephanie Kay Dodd
Liladhar Murlidhar Waykole
Raeann Wu
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41228716&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20110126(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CR20110126A publication Critical patent/CR20110126A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se preparan y se caracterizan sales de N-[6-(cis-2,6-dimetil-morfolin-4-il)-piridin-3-il]-2-metil-4'-(trifluoro-metoxi)-[1,1'-bifenil]-3-carboxamida.
CR20110126A 2008-09-17 2011-03-09 Sales de n-[6-(cis-2,6-dimetil-morfolin-4-il) -piridin-3-il] -2-metil-4'-(trifluoro-metoxi)-[1,1'-bifenil]-3-carboxamida CR20110126A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9758008P 2008-09-17 2008-09-17

Publications (1)

Publication Number Publication Date
CR20110126A true CR20110126A (es) 2011-04-27

Family

ID=41228716

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20110126A CR20110126A (es) 2008-09-17 2011-03-09 Sales de n-[6-(cis-2,6-dimetil-morfolin-4-il) -piridin-3-il] -2-metil-4'-(trifluoro-metoxi)-[1,1'-bifenil]-3-carboxamida

Country Status (39)

Country Link
US (3) US8063043B2 (es)
EP (1) EP2342198B1 (es)
JP (2) JP4897938B2 (es)
KR (2) KR20120015363A (es)
CN (1) CN102159570B (es)
AR (2) AR073591A1 (es)
AU (1) AU2009293444B2 (es)
BR (2) BRPI0918629B8 (es)
CA (1) CA2736751C (es)
CL (1) CL2011000551A1 (es)
CO (1) CO6351744A2 (es)
CR (1) CR20110126A (es)
CU (1) CU23860B1 (es)
DK (1) DK2342198T3 (es)
DO (1) DOP2011000082A (es)
EA (1) EA020048B1 (es)
EC (1) ECSP11010985A (es)
ES (1) ES2418485T3 (es)
GE (1) GEP20125592B (es)
HK (1) HK1156628A1 (es)
HN (1) HN2011000745A (es)
HR (1) HRP20130597T1 (es)
IL (1) IL211412A (es)
JO (1) JO2889B1 (es)
MA (1) MA32717B1 (es)
MX (1) MX2011002805A (es)
MY (1) MY151100A (es)
NI (1) NI201100051A (es)
NZ (1) NZ591420A (es)
PE (1) PE20110292A1 (es)
PL (1) PL2342198T3 (es)
PT (1) PT2342198E (es)
SI (1) SI2342198T1 (es)
SM (1) SMT201300072B (es)
SV (1) SV2011003857A (es)
TW (1) TWI367883B (es)
UA (1) UA103049C2 (es)
WO (1) WO2010033481A1 (es)
ZA (1) ZA201101579B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI433674B (zh) 2006-12-28 2014-04-11 Infinity Discovery Inc 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
CN101993415B (zh) * 2010-09-15 2013-08-14 北京韩美药品有限公司 作为Hedgehog通路抑制剂的化合物以及包含该化合物的药物组合物及其应用
ES2935528T3 (es) 2013-02-25 2023-03-07 Sun Pharmaceutical Ind Ltd Formulación y suspensión oral de un fármaco oncológico
WO2015092720A1 (en) * 2013-12-19 2015-06-25 Novartis Ag Metabolites of sonidegib (lde225)
WO2016155630A1 (zh) * 2015-03-30 2016-10-06 苏州晶云药物科技有限公司 N-[6-(顺式-2,6-二甲基吗啉-4-基)吡啶-3-基]-2-甲基-4'-(三氟甲氧基)[1,1'-联苯]-3-甲酰胺单磷酸盐的晶型及其制备方法
AU2016271468B2 (en) 2015-06-04 2020-01-02 Sol-Gel Technologies Ltd. Topical formulations for delivery of hedgehog inhibitor compounds and use thereof
IL261721B (en) 2016-03-15 2022-07-01 Oryzon Genomics Sa Combinations of lsd1 inhibitors for use in the treatment of solid tumors
WO2017163258A1 (en) * 2016-03-22 2017-09-28 Msn Laboratories Private Limited Process for the preparation of n-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2- methyl-4'-(trifiuoromethoxy) [1,1' -biphenyi]-3-carboxamide and its polymorphs thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4933259B2 (ja) * 2003-10-02 2012-05-16 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ピロール置換インドリノン化合物の塩および多形
GB0412468D0 (en) * 2004-06-04 2004-07-07 Astrazeneca Ab Chemical compounds
UA93548C2 (uk) * 2006-05-05 2011-02-25 Айерем Елелсі Сполуки та композиції як модулятори хеджхогівського сигнального шляху
PE20080948A1 (es) * 2006-07-25 2008-09-10 Irm Llc Derivados de imidazol como moduladores de la senda de hedgehog

Also Published As

Publication number Publication date
HN2011000745A (es) 2014-01-06
CU23860B1 (es) 2013-02-26
PL2342198T3 (pl) 2013-08-30
DK2342198T3 (da) 2013-07-01
US20110178085A1 (en) 2011-07-21
EA020048B1 (ru) 2014-08-29
BR122020009045B1 (pt) 2022-08-02
JO2889B1 (en) 2015-03-15
US20120214810A1 (en) 2012-08-23
HK1156628A1 (es) 2012-06-15
NZ591420A (en) 2012-07-27
AR073591A1 (es) 2010-11-17
ECSP11010985A (es) 2011-05-31
DOP2011000082A (es) 2011-04-15
KR20110056325A (ko) 2011-05-26
AR113778A2 (es) 2020-06-10
CA2736751A1 (en) 2010-03-25
ZA201101579B (en) 2011-11-30
MX2011002805A (es) 2011-04-11
MY151100A (en) 2014-04-15
BRPI0918629B8 (pt) 2021-05-25
US8063043B2 (en) 2011-11-22
JP2012502912A (ja) 2012-02-02
CU20110055A7 (es) 2011-12-28
UA103049C2 (uk) 2013-09-10
CN102159570A (zh) 2011-08-17
WO2010033481A1 (en) 2010-03-25
MA32717B1 (fr) 2011-10-02
SV2011003857A (es) 2011-05-16
AU2009293444B2 (en) 2012-03-15
PT2342198E (pt) 2013-07-10
PE20110292A1 (es) 2011-05-17
JP2012097104A (ja) 2012-05-24
CN102159570B (zh) 2014-01-15
NI201100051A (es) 2011-09-08
IL211412A0 (en) 2011-05-31
GEP20125592B (en) 2012-07-25
JP4897938B2 (ja) 2012-03-14
KR20120015363A (ko) 2012-02-21
BRPI0918629A2 (pt) 2020-10-27
EA201100501A1 (ru) 2011-10-31
SI2342198T1 (sl) 2013-07-31
EP2342198A1 (en) 2011-07-13
CO6351744A2 (es) 2011-12-20
TWI367883B (en) 2012-07-11
BR122020009045A2 (pt) 2020-11-10
SMT201300072B (it) 2013-09-06
EP2342198B1 (en) 2013-04-03
TW201016686A (en) 2010-05-01
KR101129088B1 (ko) 2012-03-23
CL2011000551A1 (es) 2011-07-15
IL211412A (en) 2014-07-31
US20120035174A1 (en) 2012-02-09
CA2736751C (en) 2012-10-23
AU2009293444A1 (en) 2010-03-25
HRP20130597T1 (en) 2013-07-31
ES2418485T3 (es) 2013-08-14
BRPI0918629B1 (pt) 2021-04-13

Similar Documents

Publication Publication Date Title
ECSP11010985A (es) Sales de n-[6-(cis-2,6-dimetil-morfolin-4-il)-piridin-3-il]-2-metil-4'-(trifluoro-metoxi)-[1,1'-bifenil]-3-carboxamida
CY1118379T1 (el) Αναστολεις ιου ηπατιτιδας c
CY1121017T1 (el) Κρυσταλλικες μορφες 5-χλωρο-ν2-(2-ισοπροποξυ-5-μεθυλ-4-πιπεριδιν-4-υλ-φαινυλ)-ν4-[2-(προπανο-2-σουλφονυλ)-φαινυλ]-πυριμιδιν-2,4-διαμινης
CY1116791T1 (el) 4-αρυλ-ν-φαινυλ-1,3,5-τριαζιν-αμινες που περιεχουν μια ομαδα σουλφοξιμινης
ECSP16005566A (es) Sulfonamidas como moduladores de canales de sodio
CO6741214A2 (es) Composiciones pesticidas y procesos relacionados
MX365744B (es) Derivados de sulfuro de trifluoroetilo o sustituidos con n-arilamidina como acaricidas e insecticidas.
EA201270254A1 (ru) Производные 5-фторпиримидинона
BR112015000704A2 (pt) imidazotriazinacarbonitrilas úteis como inibidores de quinase
ECSP10010582A (es) Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer
EA201001680A1 (ru) Соединения бензолсульфонамидтиазола и оксазола
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
UY34811A (es) Compuestos y composiciones para inhibir la actividad de la abl1, abl2 y bcr-abl1
UA109547C2 (uk) Композиція для боротьби з захворюванням рослин і спосіб боротьби з захворюванням рослин
UY30600A1 (es) Compuestos novedosos
EA201490596A1 (ru) Новые производные дигидрохинолин-2-она
EA201001124A1 (ru) Производные хинолина и их применение в качестве фунгицидов
PE20151994A1 (es) Modificador del sabor dulce
UA113062C2 (xx) Похідні 5-фтор-4-іміно-3-(заміщеного)-3,4-дигідропіримідин-2(1h)ону
EA201500298A1 (ru) Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы
MA32723B1 (fr) Derives d'anilino-pyrimidine a substitution sulfoximine en tant qu'inhibiteurs de cdk, leur preparation et leur utilisation comme medicaments
EA201400047A1 (ru) Производные n-оксипиразолотриазиндион
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
MA35816B1 (fr) Dérivés d'aniline, leur préparation et leur application thérapeutique
EA201270253A1 (ru) Производные n1-ацил-5-фторпиримидинона